1. Home
  2. NSP vs KALV Comparison

NSP vs KALV Comparison

Compare NSP & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Insperity Inc.

NSP

Insperity Inc.

HOLD

Current Price

$36.21

Market Cap

1.1B

ML Signal

HOLD

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$26.97

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSP
KALV
Founded
1986
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
NSP
KALV
Price
$36.21
$26.97
Analyst Decision
Hold
Strong Buy
Analyst Count
3
5
Target Price
$47.67
$32.60
AVG Volume (30 Days)
581.3K
3.2M
Earning Date
04-30-2026
07-09-2026
Dividend Yield
6.45%
N/A
EPS Growth
N/A
N/A
EPS
0.88
N/A
Revenue
$6,812,000,000.00
$50,000,000.00
Revenue This Year
$3.45
$185.42
Revenue Next Year
$6.95
$59.23
P/E Ratio
$39.17
N/A
Revenue Growth
3.51
495.66
52 Week Low
$18.57
$9.83
52 Week High
$64.49
$26.85

Technical Indicators

Market Signals
Indicator
NSP
KALV
Relative Strength Index (RSI) 67.57 75.48
Support Level $34.14 $14.25
Resistance Level $37.70 N/A
Average True Range (ATR) 1.86 0.06
MACD 0.41 -0.28
Stochastic Oscillator 99.22 95.00

Price Performance

Historical Comparison
NSP
KALV

About NSP Insperity Inc.

Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

Share on Social Networks: